<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>11</Volume><Issue>2</Issue><PubDate PubStatus="epublish"><Year>2020</Year><Month>04</Month><Day>20</Day></PubDate></Journal><title locale="en_US">Evaluation on the Effects of Tamarindus Indica L. Fruit on Body Weight and Several Cardiometabolic Risk Factors in Obese and Overweight Adult Patients: A Randomized Controlled Clinical Trial</title><FirstPage>2235</FirstPage><LastPage>2235</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Student Research Committee, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan</affiliation></Author><Author><affiliation locale="en_US">Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>20</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;strong&gt;Background&lt;/strong&gt;: Animal studies have shown the anti‑obesity effects of Tamarindus indica L. (tamarind)&lt;br /&gt;fruit pulp. This study aimed to evaluate the weight‑reducing effects of T. indica L. fruit as well as&lt;br /&gt;its blood pressure‑ and lipid‑lowering effects in a clinical trial.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods&lt;/strong&gt;: In a randomized controlled&lt;br /&gt;clinical trial, obese and overweight patients were randomly and equally assigned to tamarind and&lt;br /&gt;control groups. Both groups were instructed proper diet and maintaining physical activity for&lt;br /&gt;6 weeks. Furthermore, the participants of tamarind group were instructed to consume 10 grams&lt;br /&gt;of tamarind fruit pulp twice daily with meals for the same period. Body mass index (BMI), waist&lt;br /&gt;circumference, systolic blood pressure (SBP) and diastolic blood pressure (DBP), fasting serum&lt;br /&gt;levels of glucose (fasting plasma glucose, FPG), total cholesterol, triglycerides (TG), low‑density&lt;br /&gt;lipoprotein cholesterol (LDL‑C), and high‑density lipoprotein cholesterol (HDL‑C) were determined&lt;br /&gt;and recorded for all patients pre‑ and post‑intervention.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results&lt;/strong&gt;: Twenty patients in each group&lt;br /&gt;completed the study. Tamarind significantly reduced BMI, WC, LDL‑C, SBP, and DBP compared&lt;br /&gt;to baseline. However, none of these effects were statistically significant compared to control group.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;: Consumption of tamarind fruit pulp with daily dose of 20 g has no significant effects&lt;br /&gt;on body weight, waist circumference, serum lipid profile, blood glucose, and blood pressure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: Clinical trial, obesity, overweight, serum lipid profile, Tamarindus indica L&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2235</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2235/717718029</pdf_url></Article></Articles>
